Zim’s New Age Of Consent Law Wont Address Unintended Pregnancies Crises
By Edinah Masiyiwa In response to the pressure from early marriages and the rise of adolescent pregnancy, a new law was passed in Zimbabwe that raised the age for sexual consent from 16 to 18 years. This is known as the Criminal Laws Amendment (Protection of Children and Young Persons Act 2024) and it criminalises having sex with persons
Read More
WHO adds an HPV vaccine for single-dose use
By Staff Reporter WHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin® has been confirmed for use in a single-dose schedule. The decision is made based on new data on the product that fulfilled the criteria set out in the WHO’s 2022 recommendations for alternative, off-label use of HPV vaccines in single-dose schedules. This
Read More
Cimas Health Group CEO urges men to get screened for breast cancer.
By Staff Reporter As October marks Breast Cancer Awareness Month, Cimas Health Group Chief Executive Officer, Mr. Vuli Ndlovu, has called on men to undergo breast cancer screenings, challenging the misconception that breast cancer only affects women. Mr Ndlovu made the remarks on Friday when Cimas hosted the Cimas Pink-Tober Breast Cancer Breakfast Meetingat theirBorrowdale Office
Read More
Zimbabwe’s HPV Vaccination Coverage Nosedives
By Kudakwashe Pembere The Human Papillomavirus (HPV) vaccination coverage is failing to recover from the harsh effects of the COVID-19 era with data showing that the country is off-trail and coverage has plummeted to record low levels. Health and Child Care Minister Dr Douglas Mombeshora told this publication on the side-lines of the World Health Day
Read More
Silencing the Abused: Mbire Villagers Sweep Girls Sexual Abuse Cases Under the Rug
By Michael Gwarisa in Mbire It’s an early Friday morning, and villagers from communities surrounding Mushumbi Pools growth point in Mbire, troop to Mushumbi High School, where several partners are offering Gender Based Violence (GBV) services under a Mobile One Stop Centre setup. Over 100 women and girls arrived at the venue by 9:00 am. However,
Read More
Mobile One-Stop Centre Eases Referral Pathway Hurdles for Mbire GBV Survivors
By Michael Gwarisa in Mbire At the height of COVID-19 in 2021, when she was only 17 and about to sit for her ordinary-level examinations, Tracy Mushonga (not her real name) from Nyakatsa B1 Village in Mbire, Mashonaland Central was impregnated. She dropped out of school and went to live with her husband. A few months into her
Read MoreWard-Based Mass Drug Administration Sets Zimbabwe On Elephantiasis Elimination Trajectory
By Michael Gwarisa in Gwanda Approximately 48 Kilometres outside Gwanda town in Sifanjani Village, 68-year-old Reuben Sibanda sits amongst his fellow village men and women under a giant Baobab tree. They all listen attentively to the health worker educating them about Lymphatic Filariasis also known as Elephantiasis and why they should partake in the ongoing Mass Drug
Read More
Family led MAUC: Fighting Malnutrition amid El-Nino drought
By Caroline Chiimba Placing mothers at the center of malnutrition screening strategies acknowledges that they are in the best position to detect the earliest signs of malnutrition in their children. Using a multifaceted approach to fighting malnutrition in vulnerable communities, the EU funded ‘Enhanced Resilience for Vulnerable Households in Zimbabwe’ (ERVHIZ) project trained more that
Read MoreCIMAS Acquires Mobile Clinic
By Michael Gwairsa In a groundbreaking development, Cimas has acquired a mobile clinic, a customised motor vehicle that will be staffed by a combination of health experts to bring essential healthcare services on wheels directly to communities in need. The Cimas mobile clinic was being showcased at the just ended Zimbabwe Agricultural Society (ZAS) in Harare,
Read More
Why Africans and Europeans React To Medicines Differently: Zimbabwean Scientist Tests Effectiveness of Pharmacogenetics in African Populations
While some patients experience adverse drug reactions (ADRs) when taking medicines, others do not, and in some cases, others do not receive therapeutic benefits from treatment regardless of dosage. One reason for this inter-individual variation in response is differences in genes that code for proteins important in drug response. This has given rise to the field
Read More